Blood cell differential count discretisation modelling to predict survival in adults reporting to the emergency room: a retrospective cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 11 2023
Historique:
medline: 24 11 2023
pubmed: 23 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

To assess the survival predictivity of baseline blood cell differential count (BCDC), discretised according to two different methods, in adults visiting an emergency room (ER) for illness or trauma over 1 year. Retrospective cohort study of hospital records. Tertiary care public hospital in northern Italy. 11 052 patients aged >18 years, consecutively admitted to the ER in 1 year, and for whom BCDC collection was indicated by ER medical staff at first presentation. Survival was the referral outcome for explorative model development. Automated BCDC analysis at baseline assessed haemoglobin, mean cell volume (MCV), red cell distribution width (RDW), platelet distribution width (PDW), platelet haematocrit (PCT), absolute red blood cells, white blood cells, neutrophils, lymphocytes, monocytes, eosinophils, basophils and platelets. Discretisation cut-offs were defined by benchmark and tailored methods. Benchmark cut-offs were stated based on laboratory reference values (Clinical and Laboratory Standards Institute). Tailored cut-offs for linear, sigmoid-shaped and U-shaped distributed variables were discretised by maximally selected rank statistics and by optimal-equal HR, respectively. Explanatory variables (age, gender, ER admission during SARS-CoV2 surges and in-hospital admission) were analysed using Cox multivariable regression. Receiver operating curves were drawn by summing the Cox-significant variables for each method. Of 11 052 patients (median age 67 years, IQR 51-81, 48% female), 59% (n=6489) were discharged and 41% (n=4563) were admitted to the hospital. After a 306-day median follow-up (IQR 208-417 days), 9455 (86%) patients were alive and 1597 (14%) deceased. Increased HRs were associated with age >73 years (HR=4.6, 95% CI=4.0 to 5.2), in-hospital admission (HR=2.2, 95% CI=1.9 to 2.4), ER admission during SARS-CoV2 surges (Wave I: HR=1.7, 95% CI=1.5 to 1.9; Wave II: HR=1.2, 95% CI=1.0 to 1.3). Gender, haemoglobin, MCV, RDW, PDW, neutrophils, lymphocytes and eosinophil counts were significant overall. Benchmark-BCDC model included basophils and platelet count (area under the ROC (AUROC) 0.74). Tailored-BCDC model included monocyte counts and PCT (AUROC 0.79). Baseline discretised BCDC provides meaningful insight regarding ER patients' survival.

Identifiants

pubmed: 37993167
pii: bmjopen-2023-071937
doi: 10.1136/bmjopen-2023-071937
pmc: PMC10668290
doi:

Substances chimiques

RNA, Viral 0
Hemoglobins 0

Banques de données

Dryad
['10.5061/dryad.dncjsxm5g']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e071937

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Biol Markers. 2004 Apr-Jun;19(2):135-40
pubmed: 15255546
Int J Lab Hematol. 2022 Feb;44(1):88-95
pubmed: 34464032
Pathog Immun. 2021 Oct 07;6(2):90-104
pubmed: 34988340
Int J Lab Hematol. 2015 Oct;37(5):e119-22
pubmed: 25807967
Intensive Care Med. 2011 Jul;37(7):1136-42
pubmed: 21369810
J Hosp Med. 2007 Jan;2(1):5-12
pubmed: 17274042
J Med Biochem. 2018 Jul 01;37(3):299-306
pubmed: 30598626
Blood. 1950 Aug;5(8):723-31
pubmed: 15426653
Stat Med. 2006 Jan 15;25(1):127-41
pubmed: 16217841
Microorganisms. 2020 Dec 04;8(12):
pubmed: 33291791
Am J Clin Pathol. 2012 Jan;137(1):86-92
pubmed: 22180481
APMIS. 1992 Feb;100(2):154-8
pubmed: 1554490
PLoS One. 2021 Aug 13;16(8):e0256205
pubmed: 34388210
BMJ. 2006 May 6;332(7549):1080
pubmed: 16675816
Int J Biol Markers. 1999 Apr-Jun;14(2):115-7
pubmed: 10399631
Respirology. 2010 Jan;15(1):165-7
pubmed: 19947999
BMC Med Res Methodol. 2019 Mar 6;19(1):46
pubmed: 30841848
APMIS. 1995 Apr;103(4):261-6
pubmed: 7612256
Int J Clin Pract. 2021 Jul;75(7):e14047
pubmed: 33497517
CMAJ. 2020 Jan 13;192(2):E25-E33
pubmed: 31932337
J Natl Cancer Inst. 1980 Jul;65(1):25-32
pubmed: 6930515
BMC Med Res Methodol. 2019 May 9;19(1):96
pubmed: 31072334
Acta Anaesthesiol Scand. 1993 Apr;37(3):245-9
pubmed: 8517098
JAMA Netw Open. 2019 Dec 2;2(12):e1916526
pubmed: 31790569
J Clin Pathol. 2004 Sep;57(9):950-5
pubmed: 15333656
Ann Transl Med. 2019 Jul;7(14):311
pubmed: 31475181
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Cardiol J. 2022;29(4):637-646
pubmed: 33140390

Auteurs

Riccardo Mario Fumagalli (RM)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.
Klinik für Angiologie, UniversitätsSpital Zürich, Zurich, Switzerland.

Marco Chiarelli (M)

Dip.Chirurgico, Chirurgia Urgenza, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Massimo Cazzaniga (M)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Claudio Bonato (C)

Dipartimento Servizi Clinici, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Luciano D'Angelo (L)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Luca Cavalieri D'Oro (L)

UOC Epidemiologia, Agenzia per la Tutela della Salute Brianza, Monza, Lombardia, Italy.

Mario Cerino (M)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Sabina Terragni (S)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Elisa Lainu (E)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Cristina Lorini (C)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Claudio Scarazzati (C)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Sara Elisabetta Tazzari (SE)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Francesca Porro (F)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Simone Aldé (S)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Morena Burati (M)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

William Brambilla (W)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Stefano Nattino (S)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.
Scuola Spec. Medicina Emergenza-Urgenza, Università degli Studi di Milano, Milano, Lombardia, Italy.

Matteo Locatelli (M)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.
Polo formativo, Agenzia per la Tutela della Salute Brianza, Monza, Lombardia, Italy.

Daria Valsecchi (D)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Paolo Spreafico (P)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Valter Tantardini (V)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Gianpaolo Schiavo (G)

Dipartimento Emergenza Accettazione, Pronto Soccorso, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Mauro Pietro Zago (MP)

Dip.Chirurgico, Chirurgia Urgenza, Ospedale Alessandro Manzoni, Lecco, LC, Italy.

Luca Andrea Mario Fumagalli (LAM)

Dip.Chirurgico, Chirurgia Urgenza, Ospedale Alessandro Manzoni, Lecco, LC, Italy lu.fumagalli@asst-lecco.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH